Apellis Pharmaceuticals (APLS) call put ratio 1.2 calls to 1 put after Biogen (BIIB) acquires

Apellis Pharmaceuticals (NASDAQ: APLS) 30-day option implied volatility is at 16; compared to its 52-week range of 44 to 99. Call put ratio 1.2 calls to 1 put after Biogen (BIIB) acquired for $5.6B.

You May Also Be Interested In

• Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock
• Jefferies Upgrades Dr. Agarwals Health Care (AGARWALE:IN) to Buy
• Arista Networks (ANET) PT Raised to $250 at Evercore ISI